Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Otorhinolaryngology

Show all topics

DOI

10.1016/j.annonc.2020.04.001

License

CC-BY-NC-ND

Other Formats

PDF